Hippo pathway regulation by phosphatidylinositol transfer protein and phosphoinositides
Fu-Long Li1,2, Vivian Fu1,2, Guangbo Liu1,2
1Department of Pharmacology, University of California San Diego, La Jolla, CA, USA.
Abstract:
The Hippo pathway plays a key role in development, organ size control and tissue homeostasis, and its dysregulation contributes to cancer. The LATS tumor suppressor kinases phosphorylate and inhibit the YAP/TAZ transcriptional co-activators to suppress gene expression and cell growth. Through a screen of marine natural products, we identified microcolin B (MCB) as a Hippo activator that preferentially kills YAP-dependent cancer cells. Structure-activity optimization yielded more potent MCB analogs, which led to the identification of phosphatidylinositol transfer proteins α and β (PITPα/β) as the direct molecular targets. We established a critical role of PITPα/β in regulating LATS and YAP. Moreover, we showed that PITPα/β influence the Hippo pathway via plasma membrane phosphatidylinositol-4-phosphate. This study uncovers a previously unrecognized role of PITPα/β in Hippo pathway regulation and as potential cancer therapeutic targets.
Insights
Microcolin B activates the Hippo pathway, targeting YAP-dependent cancers. This study identifies phosphatidylinositol transfer proteins (PITPα/β) as key regulators, offering new therapeutic avenues for cancer treatment.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- The Hippo pathway regulates organ size and is crucial for tissue homeostasis.
- Dysregulation of the Hippo pathway is implicated in cancer development.
- LATS kinases inhibit YAP/TAZ co-activators, suppressing cell growth.
Purpose of the Study:
- To identify novel Hippo pathway activators from marine natural products.
- To elucidate the molecular targets and mechanisms of microcolin B (MCB).
- To explore the role of identified targets in cancer therapy.
Main Methods:
- Screening of marine natural products to identify Hippo pathway activators.
- Structure-activity relationship studies of MCB analogs.
- Biochemical assays to identify direct molecular targets.
- Investigation of PITPα/β function in Hippo pathway regulation.
Main Results:
- Microcolin B (MCB) was identified as a Hippo pathway activator that selectively kills YAP-dependent cancer cells.
- Structure-activity optimization led to more potent MCB analogs.
- Phosphatidylinositol transfer proteins α and β (PITPα/β) were identified as direct MCB targets.
- PITPα/β were found to regulate LATS and YAP activity.
- PITPα/β influence the Hippo pathway through plasma membrane phosphatidylinositol-4-phosphate.
Conclusions:
- PITPα/β play a previously unrecognized role in regulating the Hippo pathway.
- PITPα/β are potential therapeutic targets for cancer treatment.
- MCB and its analogs represent promising leads for developing novel cancer therapies targeting the Hippo pathway.
More Related Videos
07:26Single-molecule Super-resolution Imaging of Phosphatidylinositol 4,5-bisphosphate in the Plasma Membrane with Novel Fluorescent Probes
Published on: October 15, 2016
10:52Radiolabeling and Quantification of Cellular Levels of Phosphoinositides by High Performance Liquid Chromatography-coupled Flow Scintillation
Published on: January 6, 2016
Related Concept Videos
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
IP3/DAG Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
Amplifying Signals via Second Messengers
The JAK-STAT Signaling Pathway
Hedgehog Signaling Pathway
